Tuesday, July 28, 2026
Sign in Subscribe
Search Share your information
Subscribe
Live
Corporate

DBT-BIRAC Biopharma Entrepreneurship Promotion

DBT’s BIRAC (est. 2012) announced expanded support for startups in pharma/biopharma via grants and interfaces. Includes new calls for monoclonal antibodies against Nipah virus. Trending: Indigenous manufacturing push, with ₹1,000 Cr RDI outlay for private R&D.

By Whispers in the Corridors 1 min read

DBT’s BIRAC (est. 2012) announced expanded support for startups in pharma/biopharma via grants and interfaces. Includes new calls for monoclonal antibodies against Nipah virus. Trending: Indigenous manufacturing push, with ₹1,000 Cr RDI outlay for private R&D.

Share
W

Whispers in the Corridors

Reporting from the corridors of power.

Comments (0)

Comments are moderated before they appear.

No comments yet. Be the first.

Related stories

Rohit Gupta is also CMD, RRECL in Rajasthan
Corporate

Rohit Gupta is also CMD, RRECL in Rajasthan
Vaibhav Odhekar steps down as Addl. Director, Aspira Pathlab & Diagnostics Ltd
Corporate

Vaibhav Odhekar steps down as Addl. Director, Aspira Pathlab & Diagnostics Ltd
Narendra Kumar Agarwal quits as NE Director, Bhagawati Gas Ltd
Corporate

Narendra Kumar Agarwal quits as NE Director, Bhagawati Gas Ltd